173 related articles for article (PubMed ID: 23456379)
1. Plasma cytokine analysis in patients with advanced extremity melanoma undergoing isolated limb infusion.
Shetty G; Beasley GM; Sparks S; Barfield M; Masoud M; Mosca PJ; Pruitt SK; Salama AK; Chan C; Tyler DS; Weinhold KJ
Ann Surg Oncol; 2013 Apr; 20(4):1128-35. PubMed ID: 23456379
[TBL] [Abstract][Full Text] [Related]
2. Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b.
Yurkovetsky ZR; Kirkwood JM; Edington HD; Marrangoni AM; Velikokhatnaya L; Winans MT; Gorelik E; Lokshin AE
Clin Cancer Res; 2007 Apr; 13(8):2422-8. PubMed ID: 17438101
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis.
Miura JT; Kroon HM; Beasley GM; Mullen D; Farrow NE; Mosca PJ; Lowe MC; Farley CR; Kim Y; Naqvi SMH; Potdar A; Daou H; Sun J; Farma JM; Henderson MA; Speakman D; Serpell J; Delman KA; Mark Smithers B; Coventry BJ; Tyler DS; Thompson JF; Zager JS
Ann Surg Oncol; 2019 Aug; 26(8):2486-2494. PubMed ID: 30911949
[TBL] [Abstract][Full Text] [Related]
4. Isolated limb infusion for malignant melanoma: predictors of response and outcome.
Barbour AP; Thomas J; Suffolk J; Beller E; Smithers BM
Ann Surg Oncol; 2009 Dec; 16(12):3463-72. PubMed ID: 19830498
[TBL] [Abstract][Full Text] [Related]
5. Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma.
Beasley GM; Riboh JC; Augustine CK; Zager JS; Hochwald SN; Grobmyer SR; Peterson B; Royal R; Ross MI; Tyler DS
J Clin Oncol; 2011 Mar; 29(9):1210-5. PubMed ID: 21343562
[TBL] [Abstract][Full Text] [Related]
6. Australian multi-center experience outside of the Sydney Melanoma Unit of isolated limb infusion chemotherapy for melanoma.
Coventry BJ; Kroon HM; Giles MH; Henderson M; Speakman D; Wall M; Barbour A; Serpell J; Paddle P; Coventry AG; Sullivan T; Smithers BM
J Surg Oncol; 2014 Jun; 109(8):780-5. PubMed ID: 24634160
[TBL] [Abstract][Full Text] [Related]
7. First Eastern European experience of isolated limb infusion for in-transit metastatic melanoma confined to the limb: Is it still an effective treatment option in the modern era?
Teras J; Kroon HM; Thompson JF; Teras M; Pata P; Mägi A; Teras RM; Boudinot SR
Eur J Surg Oncol; 2020 Feb; 46(2):272-276. PubMed ID: 31748147
[TBL] [Abstract][Full Text] [Related]
8. Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion.
Beasley GM; Petersen RP; Yoo J; McMahon N; Aloia T; Petros W; Sanders G; Cheng TY; Pruitt SK; Seigler H; Tyler DS
Ann Surg Oncol; 2008 Aug; 15(8):2195-205. PubMed ID: 18528730
[TBL] [Abstract][Full Text] [Related]
9. Resection of residual disease after isolated limb infusion (ILI) is equivalent to a complete response after ILI-alone in advanced extremity melanoma.
Wong J; Chen YA; Fisher KJ; Beasley GM; Tyler DS; Zager JS
Ann Surg Oncol; 2014 Feb; 21(2):650-5. PubMed ID: 24162840
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: An Australian multi-center study.
Kroon HM; Coventry BJ; Henderson MA; Barbour A; Serpell J; Smithers BM; Thompson JF
Eur J Surg Oncol; 2019 May; 45(5):832-837. PubMed ID: 30867095
[TBL] [Abstract][Full Text] [Related]
11. Australian Multicenter Study of Isolated Limb Infusion for Melanoma.
Kroon HM; Coventry BJ; Giles MH; Henderson MA; Speakman D; Wall M; Barbour A; Serpell J; Paddle P; Coventry AG; Sullivan T; Smithers BM; Thompson JF
Ann Surg Oncol; 2016 Apr; 23(4):1096-103. PubMed ID: 26581203
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting survival after complete response to isolated limb perfusion in patients with in-transit melanoma.
Zogakis TG; Bartlett DL; Libutti SK; Liewehr DJ; Steinberg SM; Fraker DL; Alexander HR
Ann Surg Oncol; 2001 Dec; 8(10):771-8. PubMed ID: 11776490
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with response, survival, and limb salvage in patients undergoing isolated limb infusion.
Steinman J; Ariyan C; Rafferty B; Brady MS
J Surg Oncol; 2014 Apr; 109(5):405-9. PubMed ID: 24318953
[TBL] [Abstract][Full Text] [Related]
14. A multi-institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan-based isolated limb infusion.
Beasley GM; Sharma K; Wong J; Miller M; Turley RS; Lidsky M; Masoud M; Dewhirst MW; Mosca PJ; Zager JS; Tyler DS
Cancer; 2012 Dec; 118(24):6136-43. PubMed ID: 22674423
[TBL] [Abstract][Full Text] [Related]
15. Outcomes following isolated limb infusion for melanoma. A 14-year experience.
Kroon HM; Moncrieff M; Kam PC; Thompson JF
Ann Surg Oncol; 2008 Nov; 15(11):3003-13. PubMed ID: 18509706
[TBL] [Abstract][Full Text] [Related]
16. A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanoma.
Beasley GM; McMahon N; Sanders G; Augustine CK; Selim MA; Peterson B; Norris R; Peters WP; Ross MI; Tyler DS
Cancer; 2009 Oct; 115(20):4766-74. PubMed ID: 19637344
[TBL] [Abstract][Full Text] [Related]
17. Predicting disease progression after regional therapy for in-transit melanoma.
Lidsky ME; Turley RS; Beasley GM; Sharma K; Tyler DS
JAMA Surg; 2013 Jun; 148(6):493-8. PubMed ID: 23558401
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter Study.
Kroon HM; Coventry BJ; Giles MH; Henderson MA; Speakman D; Wall M; Barbour A; Serpell J; Paddle P; Smithers BM; Thompson JF
Ann Surg Oncol; 2017 Oct; 24(11):3245-3251. PubMed ID: 28799064
[TBL] [Abstract][Full Text] [Related]
19. A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.
Beasley GM; Caudle A; Petersen RP; McMahon NS; Padussis J; Mosca PJ; Zager JS; Hochwald SN; Grobmyer SR; Delman KA; Andtbacka RH; Noyes RD; Kane JM; Seigler H; Pruitt SK; Ross MI; Tyler DS
J Am Coll Surg; 2009 May; 208(5):706-15; discussion 715-7. PubMed ID: 19476821
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity.
Brady MS; Brown K; Patel A; Fisher C; Marx W
Ann Surg Oncol; 2006 Aug; 13(8):1123-9. PubMed ID: 16791448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
